[1] Lei JJ,Li S,Dong BX,et al.Acute intermittent porphyria: disease with low penetrance and high heterogeneity[J].Front Genet,2024,15,1374965, doi:10.3389/fgene.2024.1374965. [2] Bustad HJ,Kallio JP,Vorland M,et al.Acute intermittent porphyria:an overview of therapy developments and future perspectives focusing on stabilisation of HMBS and proteostasis regulators[J].Int J Mol Sci,2021,22,675, doi:10.3390/ijms22020675. [3] Dickey AK,Leaf RK,Balwani M.Update on the porphyrias[J].Annu Rev Med, 2024,75,321-335,doi:10.1146/annurev-med-042921-123602. [4] Li W,Lian ZY,Mi X,et al.Acute intermittent porphyria with epilepsy as the initial symptom and posterior reversible encephalopathy syndrome: a case report[J].Case Rep Neurol Med,2025,5596570,doi:10.1155/crnm/5596570. [5] Yang J,Han F,Chen Q,et al.Reversible splenial lesion syndrome(RESLES) due to acute intermittent porphyria with a novel mutation in the hydroxymethylbilane synthase gene[J].Orphanet J Rare Dis,2020,15,98, doi:10.1186/s13023-020-01375-y. [6] Buttery JE,Carrera AM,Pannall PR.Analytical sensitivity and specificity of two screening methods for urinary porphobilinogen[J].Annals of clinical biochemistry,1990, 27(Pt 2), 165-166, doi:10.1177/000456329002700217. [7] Yang J,Yang H,Chen Q,et al.Reversible MRI findings in a case of acute intermittent porphyria with a novel mutation in the porphobilinogen deaminase gene[J].Blood Cells Mol Dis,2017,63,21-24, doi:10.1016/j.bcmd.2016.12.005. [8] Wang J,Chen J,Xu K,et al.An easily overlooked disease in the early stages: acute intermittent porphyria[J].BMC Neurol,2025,25,61,doi:10.1186/s12883-025-04064-0. [9] Yang J,Chen Q,Yang H,et al.Clinical and laboratory features of acute porphyria: a study of 36 subjects in a chinese tertiary referral center[J]. BioMed Res Int,2016,3927635,doi:10.1155/2016/3927635. [10] Yusuf A,Alhaj O,Aldaheri A,et al.Rare coexistence of acute porphyria with systemic lupus erythematosus: case report and review[J].J Investig Med High Impact Case Rep,2023,11,23247096231181856, doi:10.1177/23247096231181856. [11] Oliveira Santos M,Leal Rato M. Neurology of the acute hepatic porphyrias[J]. J Neurol Sci,2021, 428,117605, doi:10.1016/j.jns.2021.117605. [12] Jaramillo-Calle DA,Solano,JM,Rabinstein AA,et al.Porphyria-induced posterior reversible encephalopathy syndrome and central nervous system dysfunction[J].Mol Genet Metab,2019,128,242-253, doi:10.1016/j.ymgme.2019.10.011. [13] Treves B,Consalvo F,Delogu G,et al.Osmotic demyel-ination syndrome: revisiting the diagnostic criteria through two fatal cases[J].BMC Neurol,2024, 24, 428, doi:10.1186/s12883-024-03934-3. [14] Chiara R,Vanessa P,Nazerian P,et al.Adult-onset of mild encephalitis/encephalopathy with reversible splenial lesion(MERS): case report and systematic review[J].Neurol Sci,2024,45,5189-5199, doi:10.1007/s10072-024-07627-0. |